Triglav Skladi D.O.O. Takes Position in The Cigna Group (NYSE:CI)

Triglav Skladi D.O.O. acquired a new stake in shares of The Cigna Group (NYSE:CI) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 29,537 shares of the health services provider’s stock, valued at approximately $8,156,000.

Other institutional investors have also recently made changes to their positions in the company. TCTC Holdings LLC purchased a new position in shares of The Cigna Group during the fourth quarter valued at about $25,000. Collier Financial purchased a new position in shares of The Cigna Group during the fourth quarter valued at about $32,000. Compagnie Lombard Odier SCmA purchased a new position in The Cigna Group in the fourth quarter worth about $37,000. Transce3nd LLC purchased a new position in The Cigna Group in the fourth quarter worth about $38,000. Finally, Heck Capital Advisors LLC purchased a new position in The Cigna Group in the fourth quarter worth about $53,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

The Cigna Group Stock Performance

The Cigna Group stock opened at $320.68 on Monday. The company has a 50 day moving average price of $325.00 and a 200-day moving average price of $309.88. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a market capitalization of $85.67 billion, a PE ratio of 26.20, a P/E/G ratio of 0.98 and a beta of 0.47.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating the consensus estimate of $6.35 by $0.39. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The firm had revenue of $65.45 billion during the quarter, compared to the consensus estimate of $60.39 billion. During the same quarter in the previous year, the firm posted $6.47 earnings per share. The company’s revenue was up 14.4% on a year-over-year basis. As a group, equities analysts forecast that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 1.88%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group’s dividend payout ratio (DPR) is 33.44%.

Insider Buying and Selling

In related news, CEO David Cordani sold 26,527 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the transaction, the chief executive officer now owns 127,767 shares of the company’s stock, valued at $39,367,568.04. The trade was a 17.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Noelle K. Eder sold 9,944 shares of The Cigna Group stock in a transaction on Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the completion of the transaction, the insider now directly owns 13,406 shares in the company, valued at $4,289,920. This represents a 42.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock valued at $13,603,991 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on CI. Cowen reiterated a “buy” rating on shares of The Cigna Group in a research report on Monday, May 5th. Guggenheim reiterated a “buy” rating and issued a $388.00 price target (up previously from $384.00) on shares of The Cigna Group in a research report on Monday, May 5th. Raymond James reiterated a “strong-buy” rating and issued a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Royal Bank of Canada set a $355.00 price target on The Cigna Group in a research report on Friday, January 31st. Finally, Wells Fargo & Company dropped their price target on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. Two research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, The Cigna Group presently has an average rating of “Buy” and an average target price of $379.33.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.